Jeremy Levin, SVP Strat Transactions at Bristol-Myers Squibb, holds 3.65M shares in Ovid Therapeutics (Ticker: OVID), holds 43.69K shares in Bristol-Myers Squibb (Ticker: BMY). Most recently, Jeremy Levin Bought ― shares of Ovid Therapeutics on Mar 20, 2024 for an estimated value of 50.36K.